BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, van Sandick JW, Cats A, Verheij M, Coebergh JW, van de Velde CJ. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer. 2012;48:1624-1632. [PMID: 22317953 DOI: 10.1016/j.ejca.2012.01.009] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Stordeur S, Vlayen J, Vrijens F, Camberlin C, De Gendt C, Van Eycken E, Lerut T. Quality indicators for oesophageal and gastric cancer: a population-based study in Belgium, 2004-2008: Quality indicators for upper GI cancer. Eur J Cancer Care (Engl) 2015;24:376-86. [DOI: 10.1111/ecc.12279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
2 Toxopeus E, Lynam-Lennon N, Biermann K, Dickens G, de Ruiter PE, van Lanschot J, Reynolds JV, Wijnhoven B, O'Sullivan J, van der Laan L. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma. Exp Biol Med (Maywood) 2019;244:1210-9. [PMID: 31390899 DOI: 10.1177/1535370219868671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Jooste V, Manfredi S, Napoleon M, Drouillard A, Marref I, Bedenne L, Faivre J, Bouvier A. Patterns of care and outcomes in oesophageal cancer. Digestive and Liver Disease 2018;50:1238-43. [DOI: 10.1016/j.dld.2018.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 van Workum F, Bouwense SA, Luyer MD, Nieuwenhuijzen GA, van der Peet DL, Daams F, Kouwenhoven EA, van Det MJ, van den Wildenberg FJ, Polat F, Gisbertz SS, Henegouwen MI, Heisterkamp J, Langenhoff BS, Martijnse IS, Grutters JP, Klarenbeek BR, Rovers MM, Rosman C. Intrathoracic versus Cervical ANastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trial. Trials. 2016;17:505. [PMID: 27756419 DOI: 10.1186/s13063-016-1636-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
5 Koëter M, Kathiravetpillai N, Gooszen JA, van Berge Henegouwen MI, Gisbertz SS, van der Sangen MJ, Luyer MD, Nieuwenhuijzen GA, Hulshof MC. Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis. Int J Radiat Oncol Biol Phys 2017;97:813-21. [PMID: 28244418 DOI: 10.1016/j.ijrobp.2016.11.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
6 Anderegg MCJ, van der Sluis PC, Ruurda JP, Gisbertz SS, Hulshof MCCM, van Vulpen M, Mohammed NH, van Laarhoven HWM, Wiezer MJ, Los M, van Berge Henegouwen MI, van Hillegersberg R. Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2017;24:2282-2290. [PMID: 28424936 DOI: 10.1245/s10434-017-5827-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
7 Nicolas C, Sylvain M, Come L, Jean F, Anne-Marie B, Valérie J. Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population. Gastric Cancer 2016;19:508-14. [PMID: 26118904 DOI: 10.1007/s10120-015-0509-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
8 Chen C, Yang JM, Hu TT, Xu TJ, Yan G, Hu SL, Wei W, Xu WP. Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis. Arch Med Res. 2013;44:380-389. [PMID: 23871709 DOI: 10.1016/j.arcmed.2013.07.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
9 Kestens C, Offerhaus GJA, van Baal JW, Siersema PD. Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer. Clinical Gastroenterology and Hepatology 2016;14:956-962.e1. [DOI: 10.1016/j.cgh.2015.12.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
10 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
11 Yang J, Xu C, Lian D, Ye S, Zeng Z, Liu D, Zhuang C. Esophageal reconstruction: posterior mediastinal or retrosternal route. J Surg Res 2016;201:364-9. [PMID: 27020820 DOI: 10.1016/j.jss.2015.11.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN. Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. J Carcinog 2015;14:5. [PMID: 26085818 DOI: 10.4103/1477-3163.157441] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Nucci D, Marino A, Realdon S, Nardi M, Fatigoni C, Gianfredi V. Lifestyle, WCRF/AICR Recommendations, and Esophageal Adenocarcinoma Risk: A Systematic Review of the Literature. Nutrients 2021;13:3525. [PMID: 34684526 DOI: 10.3390/nu13103525] [Reference Citation Analysis]
14 Verstegen MHP, Harker M, van de Water C, van Dieren J, Hugen N, Nagtegaal ID, Rosman C, van der Post RS. Metastatic pattern in esophageal and gastric cancer: Influenced by site and histology. World J Gastroenterol 2020; 26(39): 6037-6046 [PMID: 33132653 DOI: 10.3748/wjg.v26.i39.6037] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
15 de Bekker-Grob EW, Niers EJ, van Lanschot JJ, Steyerberg EW, Wijnhoven BP. Patients' Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment. World J Surg 2015;39:2492-9. [PMID: 26170156 DOI: 10.1007/s00268-015-3148-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
16 Yura M, Takeuchi H, Fukuda K, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y. High-risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma. Ann Gastroenterol Surg 2018;2:419-27. [PMID: 30460345 DOI: 10.1002/ags3.12215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dassen AE, Dikken JL, van de Velde CJ, Wouters MW, Bosscha K, Lemmens VE. Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in The Netherlands. Int J Cancer. 2013;133:1859-1866. [PMID: 23564267 DOI: 10.1002/ijc.28192] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
18 Kestens C, Siersema PD, van Baal JW. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World J Gastroenterol 2016; 22(1): 1-7 [PMID: 26755856 DOI: 10.3748/wjg.v22.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
20 Van De Voorde L, Janssen L, Larue R, Houben R, Buijsen J, Sosef M, Vanneste B, Schraepen M, Berbée M, Lambin P. Can metformin improve ‘the tomorrow’ of patients treated for oesophageal cancer? European Journal of Surgical Oncology (EJSO) 2015;41:1333-9. [DOI: 10.1016/j.ejso.2015.05.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bernards N, Haj Mohammad N, Creemers GJ, Rozema T, Roukema JA, Nieuwenhuijzen GA, van Laarhoven HW, van der Sangen M, Lemmens VE. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013. Acta Oncol. 2016;55:1161-1167. [PMID: 27174793 DOI: 10.1080/0284186x.2016.1176249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Seesing MFJ, Gisbertz SS, Goense L, van Hillegersberg R, Kroon HM, Lagarde SM, Ruurda JP, Slaman AE, van Berge Henegouwen MI, Wijnhoven BPL. A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands. Annals of Surgery 2017;266:839-46. [DOI: 10.1097/sla.0000000000002393] [Cited by in Crossref: 91] [Cited by in F6Publishing: 45] [Article Influence: 22.8] [Reference Citation Analysis]
23 Mulder FI, Hovenkamp A, van Laarhoven HWM, Büller HR, Kamphuisen PW, Hulshof MCCM, van Berge Henegouwen MI, Middeldorp S, van Es N. Thromboembolic and bleeding complications in patients with oesophageal cancer. Br J Surg 2020;107:1324-33. [PMID: 32424862 DOI: 10.1002/bjs.11665] [Reference Citation Analysis]
24 Honing J, Pavlov KV, Mul VE, Karrenbeld A, Meijer C, Faiz Z, Smit JK, Hospers GA, Burgerhof JG, Kruyt FA, Kleibeuker JH, Plukker JT. CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Radiotherapy and Oncology 2015;117:152-8. [DOI: 10.1016/j.radonc.2015.08.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
25 Kestens C, Siersema PD, Offerhaus GJ, van Baal JW. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2. PLoS One 2016;11:e0155754. [PMID: 27191723 DOI: 10.1371/journal.pone.0155754] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Lee SW, Kaji M, Uenosono Y, Kano M, Shimizu H, Noguchi T, Ueda S, Nobuoka T, Oshio A, Nakada K. The evaluation of the postoperative quality of life in patients undergoing radical gastrectomy for esophagogastric junction cancer using the Postgastrectomy Syndrome Assessment Scale-45: a nationwide multi-institutional study. Surg Today 2021. [PMID: 34734320 DOI: 10.1007/s00595-021-02400-8] [Reference Citation Analysis]
27 Busweiler L, Henneman D, Dikken J, Fiocco M, van Berge Henegouwen M, Wijnhoven B, van Hillegersberg R, Rosman C, Wouters M, van Sandick J, Bosscha K, Cats A, van Grieken N, Hartgrink H, Lemmens V, Nieuwenhuijzen G, Plukker J, Siersema P, Tetteroo G, Veldhuis P, Voncken F. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer. European Journal of Surgical Oncology (EJSO) 2017;43:1962-9. [DOI: 10.1016/j.ejso.2017.07.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
28 Busweiler LAD, Wijnhoven BPL, van Berge Henegouwen MI, Henneman D, van Grieken NCT, Wouters MWJM, van Hillegersberg R, van Sandick JW, Bosscha K, Cats A, Dikken JL, Hartgrink HH, Jong PC, Lemmens VEPP, Nieuwenhuijzen GAP, Plukker JT, Rosman C, Rozema T, Siersema PD, Tetteroo G, Veldhuis PMJF, Voncken FEM. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. British Journal of Surgery 2016;103:1855-63. [DOI: 10.1002/bjs.10303] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 15.2] [Reference Citation Analysis]
29 Massl R, van Blankenstein M, Jeurnink S, Hermans JJ, de Haan MC, Stoker J, Koek M, Niessen WJ, Steyerberg EW, Looman CW. Visceral adipose tissue: the link with esophageal adenocarcinoma. Scand J Gastroenterol. 2014;49:449-457. [PMID: 24467299 DOI: 10.3109/00365521.2013.873818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
30 van der Kaaij RT, Voncken FEM, van Dieren JM, Snaebjornsson P, Korse CM, Grootscholten C, Aleman BMP, van Sandick JW. Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma. Am J Clin Oncol 2019;42:345-50. [PMID: 30724779 DOI: 10.1097/COC.0000000000000525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191-202. [PMID: 24092861 DOI: 10.1136/gutjnl-2013-305490] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 10.1] [Reference Citation Analysis]
32 van Nistelrooij AM, van Marion R, Biermann K, Spaander MC, van Lanschot JJ, Wijnhoven BP, Dinjens WN; PALGA-group. Early onset esophageal adenocarcinoma: a distinct molecular entity? Oncoscience 2016;3:42-8. [PMID: 26973859 DOI: 10.18632/oncoscience.290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D; ESMO Guidelines Working Group. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi51-vi56. [PMID: 24078662 DOI: 10.1093/annonc/mdt342] [Cited by in Crossref: 131] [Cited by in F6Publishing: 124] [Article Influence: 18.7] [Reference Citation Analysis]
34 Talsma AK, Damhuis RAM, Steyerberg EW, Rosman C, van Lanschot JJB, Wijnhoven BPL. Determinants of improved survival after oesophagectomy for cancer. British Journal of Surgery 2015;102:668-75. [DOI: 10.1002/bjs.9792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
35 Blom RL, Bogush T, Brücher BL, Chang AC, Davydov M, Dudko E, Leong T, Polotsky B, Swanson PE, van Rossum PS, Ruurda JP, Sagaert X, Tjulandin S, Schraepen MC, Sosef MN, van Hillegersberg R. Therapeutic approaches to gastroesophageal junction adenocarcinomas. Ann N Y Acad Sci 2014;1325:197-210. [PMID: 25266026 DOI: 10.1111/nyas.12532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 van der Kaaij RT, de Rooij MV, van Coevorden F, Voncken FEM, Snaebjornsson P, Boot H, van Sandick JW. Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery. Br J Surg. 2018;105:561-569. [PMID: 29465746 DOI: 10.1002/bjs.10729] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
37 Scholtemeijer MG, Seesing MFJ, Brenkman HJF, Janssen LM, van Hillegersberg R, Ruurda JP. Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 2017;9:S868-78. [PMID: 28815085 DOI: 10.21037/jtd.2017.06.92] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
38 Haverkamp L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, Bonenkamp JJ, Bisseling TM, Siersema PD, Sosef MN, Stoot JH, Beets GL, de Steur WO, Hartgrink HH, Verspaget HW, van der Peet DL, Plukker JT, van Etten B, Wijnhoven BPL, van Lanschot JJ, van Hillegersberg R, Ruurda JP. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands: Esophageal and gastric cancer pearl. Dis Esophagus 2016;29:435-41. [DOI: 10.1111/dote.12347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
39 Huang Q, Read M, Gold JS, Zou XP. Unraveling the identity of gastric cardiac cancer. J Dig Dis 2020;21:674-86. [PMID: 32975049 DOI: 10.1111/1751-2980.12945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Nakanishi R, Shimizu T, Kumagai K, Takai A, Marusawa H. Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs. Pathogens 2021;10:453. [PMID: 33918902 DOI: 10.3390/pathogens10040453] [Reference Citation Analysis]
41 Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. European Journal of Cancer 2014;50:1330-44. [DOI: 10.1016/j.ejca.2014.01.029] [Cited by in Crossref: 353] [Cited by in F6Publishing: 361] [Article Influence: 50.4] [Reference Citation Analysis]
42 Holster IL, Aarts MJ, Tjwa ET, Lemmens VE, Kuipers EJ. Trend breaks in incidence of non-cardia gastric cancer in the Netherlands. Cancer Epidemiol 2014;38:9-15. [PMID: 24309073 DOI: 10.1016/j.canep.2013.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
43 Huang Q, Sun Q, Fan XS, Zhou D, Zou XP. Recent advances in proximal gastric carcinoma. J Dig Dis. 2016;17:421-432. [PMID: 27129018 DOI: 10.1111/1751-2980.12355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
44 Kroep S, Lansdorp-vogelaar I, Rubenstein JH, Lemmens VEPP, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM. Comparing Trends in Esophageal Adenocarcinoma Incidence and Lifestyle Factors Between the United States, Spain, and The Netherlands. American Journal of Gastroenterology 2014;109:336-43. [DOI: 10.1038/ajg.2013.420] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
45 van Nistelrooij AM, Dinjens WN, Wagner A, Spaander MC, van Lanschot JJ, Wijnhoven BP. Hereditary Factors in Esophageal Adenocarcinoma. Gastrointest Tumors. 2014;1:93-98. [PMID: 26675496 DOI: 10.1159/000362575] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
46 Toxopeus ELA, de Man FM, Krak N, Biermann K, Nieuweboer AJM, Friberg LE, Oomen-de Hoop E, van Lanschot JJB, Shapiro J, Wijnhoven BPL, Mathijssen RHJ. Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer. Cancers (Basel) 2019;11:E173. [PMID: 30717316 DOI: 10.3390/cancers11020173] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249. [PMID: 33538338 DOI: 10.3322/caac.21660] [Cited by in Crossref: 1471] [Cited by in F6Publishing: 2139] [Article Influence: 1471.0] [Reference Citation Analysis]
48 Dassen AE, Dikken JL, Bosscha K, Wouters MW, Cats A, van de Velde CJ, Coebergh JW, Lemmens VE. Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol. 2014;53:138-142. [PMID: 23829603 DOI: 10.3109/0284186x.2013.789139] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
49 Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40. [PMID: 28815069 DOI: 10.21037/jtd.2017.03.171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
50 Nelen SD, van Putten M, Lemmens VEPP, Bosscha K, de Wilt JHW, Verhoeven RHA. Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer. Br J Surg. 2017;104:1837-1846. [PMID: 28791679 DOI: 10.1002/bjs.10621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
51 van der Kaaij RT, Snaebjornsson P, Voncken FE, van Dieren JM, Jansen EP, Sikorska K, Cats A, van Sandick JW. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma. European Journal of Cancer 2017;76:27-35. [DOI: 10.1016/j.ejca.2017.01.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
52 Becker C, Meier CR, Jick SS, Bodmer M. Case-control analysis on metformin and cancer of the esophagus. Cancer Causes Control. 2013;24:1763-1770. [PMID: 23820930 DOI: 10.1007/s10552-013-0253-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
53 Devadas M, Mittal A, Lin M, Cosman P, Ziazaris W, Wilson R, Das A, Merrett N. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers. International Journal of Surgery 2015;20:113-7. [DOI: 10.1016/j.ijsu.2015.06.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
54 Nelen SD, Verhoeven RHA, Lemmens VEPP, de Wilt JHW, Bosscha K. Increasing survival gap between young and elderly gastric cancer patients. Gastric Cancer 2017;20:919-28. [PMID: 28275933 DOI: 10.1007/s10120-017-0708-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
55 Henneman D, Dikken JL, Putter H, Lemmens VE, Van der Geest LG, van Hillegersberg R, Verheij M, van de Velde CJ, Wouters MW. Centralization of esophagectomy: how far should we go? Ann Surg Oncol 2014;21:4068-74. [PMID: 25005073 DOI: 10.1245/s10434-014-3873-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
56 van Nistelrooij AM, van Marion R, Koppert LB, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Wijnhoven BP, Dinjens WN. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples. BMC Res Notes 2017;10:144. [PMID: 28376920 DOI: 10.1186/s13104-017-2456-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
57 Hosoda K, Azuma M, Katada C, Ishido K, Niihara M, Ushiku H, Sakuraya M, Washio M, Wada T, Watanabe A, Harada H, Tanabe S, Koizumi W, Yamashita K, Hiki N. A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction. Int J Clin Oncol 2020;25:1090-7. [PMID: 32124094 DOI: 10.1007/s10147-020-01638-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M; Japanese Gastric Cancer Association and the Japan Esophageal Society. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69-83. [PMID: 27796514 DOI: 10.1007/s10120-016-0663-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
59 Koppert LB, Lemmens VE, Coebergh JW, Steyerberg EW, Wijnhoven BP, Tilanus HW, Janssen-Heijnen ML. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg. 2012;99:1693-1700. [PMID: 23132417 DOI: 10.1002/bjs.8952] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
60 van Erp NF, Helsper CW, Slottje P, Brandenbarg D, Büchner FL, van Asselt KM, Muris J, Kortekaas MF, Peeters P, de Wit NJ. Time to diagnosis of symptomatic gastric and oesophageal cancer in the Netherlands: Where is the room for improvement? United European Gastroenterol J 2020;8:607-20. [PMID: 32250202 DOI: 10.1177/2050640620917804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 van der Kaaij RT, Koemans WJ, van Putten M, Snaebjornsson P, Luijten JCHBM, van Dieren JM, Cats A, Lemmens VEPP, Verhoeven RHA, van Sandick JW. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer 2020;130:23-31. [PMID: 32171106 DOI: 10.1016/j.ejca.2020.02.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
62 Koëter M, van Steenbergen LN, Lemmens VE, Rutten HJ, Roukema JA, Wijnhoven BP, Nieuwenhuijzen GA. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer. Eur J Surg Oncol 2014;40:1338-45. [PMID: 24484779 DOI: 10.1016/j.ejso.2013.12.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
63 Versteijne E, van Laarhoven HW, van Hooft JE, van Os RM, Geijsen ED, van Berge Henegouwen MI, Hulshof MC. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern. Dis Esophagus 2015;28:453-9. [PMID: 24725186 DOI: 10.1111/dote.12215] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
64 Dikken JL, Dassen AE, Lemmens VE, Putter H, Krijnen P, van der Geest L, Bosscha K, Verheij M, van de Velde CJ, Wouters MW. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer. 2012;48:1004-1013. [PMID: 22456179 DOI: 10.1016/j.ejca.2012.02.064] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 10.7] [Reference Citation Analysis]
65 Steenhagen E, van Vulpen JK, van Hillegersberg R, May AM, Siersema PD. Nutrition in peri-operative esophageal cancer management. Expert Rev Gastroenterol Hepatol. 2017;11:663-672. [PMID: 28454509 DOI: 10.1080/17474124.2017.1325320] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
66 Nelen SD, Heuthorst L, Verhoeven RHA, Polat F, Kruyt PM, Reijnders K, Ferenschild FTJ, Bonenkamp JJ, Rutter JE, de Wilt JHW, Spillenaar Bilgen EJ. Impact of Centralizing Gastric Cancer Surgery on Treatment, Morbidity, and Mortality. J Gastrointest Surg. 2017;21:2000-2008. [PMID: 28815471 DOI: 10.1007/s11605-017-3531-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
67 de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 [PMID: 31885424 DOI: 10.3748/wjg.v25.i47.6835] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
68 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hong Y, Chen H, Rao Z, Peng B, Hu H, Lin S, Xu Z. In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction. Exp Ther Med 2018;15:3103-7. [PMID: 29456713 DOI: 10.3892/etm.2018.5744] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Pattamatta M, Fransen LFC, Dolmans-Zwartjes ACP, Nieuwenhuijzen GAP, Evers SMAA, Kouwenhoven EA, van Det MJ, Hiligsmann M, Luyer MDP. Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of life. J Med Econ 2021;24:54-60. [PMID: 33274674 DOI: 10.1080/13696998.2020.1859843] [Reference Citation Analysis]
71 Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4:e137-e147. [PMID: 30733056 DOI: 10.1016/s2468-2667(18)30267-6] [Cited by in Crossref: 150] [Cited by in F6Publishing: 89] [Article Influence: 75.0] [Reference Citation Analysis]
72 Kjaer DW, Nassar M, Jensen LS, Svendsen LB, Mortensen FV. A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database. Dis Esophagus 2017;30:1-7. [PMID: 27001181 DOI: 10.1111/dote.12474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 de Gouw DJJM, Rijpkema M, de Bitter TJJ, Baart VM, Sier CFM, Hernot S, van Dam GM, Nagtegaal ID, Klarenbeek BR, Rosman C, van der Post RS. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging. Mol Diagn Ther 2020;24:191-200. [PMID: 32048177 DOI: 10.1007/s40291-020-00448-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
74 Jiang X, Tseng CC, Bernstein L, Wu AH. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer 2014;14:60. [PMID: 24495377 DOI: 10.1186/1471-2407-14-60] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
75 van Putten M, Koëter M, van Laarhoven HWM, Lemmens VEPP, Siersema PD, Hulshof MCCM, Verhoeven RHA, Nieuwenhuijzen GAP. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer. Annals of Surgery 2018;267:303-10. [DOI: 10.1097/sla.0000000000002063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]
76 Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma. Iran Red Crescent Med J 2013;15:547-53. [PMID: 24396572 DOI: 10.5812/ircmj.11847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
77 van Putten M, de Vos-Geelen J, Nieuwenhuijzen GAP, Siersema PD, Lemmens VEPP, Rosman C, van der Sangen MJC, Verhoeven RHA. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer. 2018;94:138-147. [PMID: 29571082 DOI: 10.1016/j.ejca.2018.02.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
78 van Nistelrooij A, Zwarthoff E, Post E, Lurkin I, van Marion R, Kopershoek E, Biermann K, Wijnhoven B, Dinjens W. Absence of TERT promoter mutations in esophageal adenocarcinoma: Letter to the Editor. Int J Cancer 2014;134:2014-5. [DOI: 10.1002/ijc.28527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
79 van Nistelrooij AMJ, van Marion R, van Ijcken WFJ, de Klein A, Wagner A, Biermann K, Spaander MCW, van Lanschot JJB, Dinjens WNM, Wijnhoven BPL. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma. Fam Cancer 2018;17:435-40. [PMID: 29134539 DOI: 10.1007/s10689-017-0054-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
80 Koëter M, Parry K, Verhoeven RHA, Luyer MDP, Ruurda JP, van Hillegersberg R, Lemmens VEPP, Nieuwenhuijzen GAP. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands. Ann Surg Oncol 2016;23:1632-8. [DOI: 10.1245/s10434-015-5061-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
81 Ding G, Wang Y, Chen Y, Yin J, Liu C, Fan Y, Qiu H, Tang W, Chen S. Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects. Oncotarget 2017;8:111482-94. [PMID: 29340069 DOI: 10.18632/oncotarget.22845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
82 van Nistelrooij AM, van Steenbergen LN, Spaander MC, Tilanus HW, van Lanschot JJ, Lemmens VE, Wijnhoven BP. Treatment and outcome of young patients with esophageal cancer in the Netherlands. J Surg Oncol 2014;109:561-6. [PMID: 24338660 DOI: 10.1002/jso.23533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
83 Tokunaga R, Imamura Y, Nakamura K, Ishimoto T, Nakagawa S, Miyake K, Nakaji Y, Tsuda Y, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Saeki H, Yoshida N, Oki E, Watanabe M, Oda Y, Bass AJ, Maehara Y, Baba H. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma. Oncotarget 2016;7:19748-61. [PMID: 26933914 DOI: 10.18632/oncotarget.7782] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
84 Peppelenbosch MP, Spaander MCW, Bruno MJ. Glutathione peroxidase 7 prevents cancer in the oesophagus. Gut 2014;63:537-8. [DOI: 10.1136/gutjnl-2013-304906] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
85 Mantoan S, Cavallin F, Pinto E, Saadeh LM, Alfieri R, Cagol M, Bellissimo MC, Castoro C, Scarpa M. Long-term quality of life after esophagectomy with gastric pull-up. J Surg Oncol 2018;117:970-6. [PMID: 29409116 DOI: 10.1002/jso.24995] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
86 Verstegen MHP, Bouwense SAW, van Workum F, Ten Broek R, Siersema PD, Rovers M, Rosman C. Management of intrathoracic and cervical anastomotic leakage after esophagectomy for esophageal cancer: a systematic review. World J Emerg Surg 2019;14:17. [PMID: 30988695 DOI: 10.1186/s13017-019-0235-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
87 Wilson EE, Thompson SK, Bull J, Jones B, Price T, Devitt PG, Watson DI, Bright T. Improving care for patients with oesophageal and gastric cancer: impact of a statewide multidisciplinary team: Statewide upper GI cancer MDT. ANZ J Surg 2016;86:270-3. [DOI: 10.1111/ans.12869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]